Clinical trial
Fluoxetine Treatment of Depression in Adults With Down Syndrome
NCT05458479 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluoxetine Treatment of Depression in Adults With Down Syndrome
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 5, 2022
- Completion date
- February 26, 2024
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression, down syndrome